Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>> Download now...

RHEI Licenses China Rights to ADHA Nutraceutical

publication date: Feb 20, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

RHEI Pharmaceuticals, Inc., a US company that seeks to bring proprietary medications to China, licensed the China marketing rights for Attental from MethaPharma. Attental is a nutraceutical drug available in Europe to treat symptoms of ADHD in children. MethaPharma, a division of Vemedia Group, is headquartered in Belgium. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners